This content is from: Features

Derivatives after the crash

Rosali Pretorius and Tom Harkus of Dentons consider the key objectives of Emir and their impact on the buy-side’s use of OTC derivatives

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.


Are you already an IFLR subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial